| dc.date.accessioned | 2021-01-19T10:06:54Z | |
| dc.date.available | 2021-01-19T10:06:54Z | |
| dc.identifier.citation | [2021] ZACC 35 | |
| dc.identifier.citation | 2022 (5) BCLR 532 (CC) | |
| dc.identifier.citation | 2022 (4) SA 323 (CC) | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12144/36732 | |
| dc.title | Competition Commission of South Africa v Mediclinic Southern Africa (Pty) Ltd and Another | en_US |
| dc.identifier.casenumber | CCT 31/20 | |
| dc.date.hearing | 11 March 2021 | |
| dc.contributor.judge | Mogoeng CJ (majority) | |
| dc.contributor.judge | Theron J (dissenting) | |
| dc.date.judgment | 15 October 2021 | |
| dc.link.judgment | https://collections.concourt.org.za/bitstream/handle/20.500.12144/36732/Judgment%20CCT%2031-20%20Competition%20Commission%20of%20South%20Africa%20v%20Medi....pdf?sequence=35&isAllowed=y | |
| dc.concourt.synopsis | section 12A of the Competition Act 89 of 1998 — substantial lessening of competition — impact of a merger on competition —impact on section 27 of the Constitution — interpretation in accordance with sections 7(2) and 39(2) of the Constitution — interference by appellate courts with findings of trial courts Competition Appeal Court not entitled to interfere with findings of the Tribunal — appeal is upheld — no order as to costs | |
| dc.concourt.casehistory | On appeal from the Competition Appeal Court of South Africa (hearing an appeal from the Competition Tribunal) |